REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/13/2026
Back to search
Official data from USPTO
BAXALTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
03/14/2026
Trademark type
Combined
Nice classes
5, 10, 41
Filing date
05/12/2015
Registration date
11/22/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2023
Last transaction
03/14/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Bannockburn, IL, US
Examiner
BLANDU, FLORENTINA
Law office
M80
Mark description
The mark consists of the word "BAXALTA" with light rays emanating from the center of the letter "X".
Holders and representatives
Holders
B. I. (pessoa física)
Representatives
A. Tally Eitan Gornitzky & Co
Technical classification
Nice Classes
Class 5Class 10Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationssubstances and products for the treatment of blood diseases and disordersimmuno deficiency disorderscancer; pharmaceuticals for the treatment of blood diseases and disordersimmuno deficiency disorderscancer; pharmaceutical preparationsproteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disordersall containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteralintramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparationschemotherapeutic agents
Class 10
Medical devicesdevices for reconstituting dried pharmaceuticals; medical apparatus and instrumentsmedical infusion set for subcutaneous delivery of pharmaceuticals; medical apparatus for the preparation and parental infusion of pharmaceutical preparations
Class 41
Education and training servicesproviding classesseminarsconferenceslectures and workshops in the fields of pharmaceuticalshealth carehealth insurancemedical informationbleeding disorders or conditionshemophiliahematologyimmunologyoncology and patient care; education servicesproviding printed publications in the nature of newsletters and white papers in the field of hemophilia; provision of information for training and teaching relating to pharmaceuticalshealth carehealth insurancemedical informationbleeding disorders or conditionshemophiliahematologyimmunologyoncology and patient care; provision of non-downloadable electronic publicationsnewslettersarticlesbrochures and booklets in the field of pharmaceuticalshealth carehealth insurancemedical informationbleeding disorders or conditionshemophiliahematologyimmunologyoncology and patient care
Publications
History of USPTO decisions and trademark events.
50 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
03/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/28/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/20/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/26/2023
INPC
INVALIDATION PROCESSED
10/26/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
10/24/2023
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/24/2023
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
02/24/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/24/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/22/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/21/2022
ES71
TEAS SECTION 71 RECEIVED
08/22/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/22/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/25/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/07/2017
FIMP
FINAL DISPOSITION PROCESSED
03/07/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/22/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/22/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2016
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/01/2016
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/16/2016
CHPB
POST PUBLICATION AMENDMENT - ENTERED
02/16/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2016
PUBO
PUBLISHED FOR OPPOSITION
02/16/2016
GPNX
NOTIFICATION PROCESSED BY IB
02/13/2016
APET
ASSIGNED TO PETITION STAFF
02/05/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/27/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/27/2016
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
01/18/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/18/2015
ALIE
ASSIGNED TO LIE
12/18/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/19/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/19/2015
RFNT
REFUSAL PROCESSED BY IB
09/25/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/08/2015
RFRR
REFUSAL PROCESSED BY MPU
09/08/2015
MAFR
APPLICATION FILING RECEIPT MAILED
09/08/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/06/2015
CNRT
NON-FINAL ACTION WRITTEN
09/05/2015
DOCK
ASSIGNED TO EXAMINER
09/02/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/02/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/27/2015
Continuous trademark protection
Get notified about every new filing that threatens BAXALTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.